Literature DB >> 1323852

Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses.

J L Kolman1, C J Kolman, G Miller.   

Abstract

Epstein-Barr virus (EBV) genomes in the P3J-HR-1 (HR-1) Burkitt lymphoma cell line rearrange at a high rate. Previously described deletions and rearrangements in HR-1 cells have been found at sites of EBV replication in vivo, suggesting that DNA rearrangement may be an integral aspect of EBV biology and pathogenesis. We examined the structure of linear EBV genomes in subcultures of HR-1 cells using contour-clamped homogenous electric field gel electrophoresis. We developed a second pulsed electrophoretic technique to separate intracellular circular EBV plasmids. The standard, linear HR-1 EBV genome was approximately 155 kilobases in length. Linear molecules of less than unit length, presumably defective genomes, were seen in numerous subcultures. Linear intracellular genomes greater than 155 kilobases were also detected, but only linear genomes of 155 kilobases or less were packaged into virions. The size of circular EBV plasmids also varied greatly among HR-1 subcultures, some of which contained two plasmids of different size. The progeny of the unusual circular plasmids could be either standard or nonstandard linear genomes. No aberrant linear or circular form was detected in a subculture carrying the previously described het fragments. Pulsed-gel electrophoresis has provided two additional characteristics of mutant EBVs: abnormal linear and circular genome configurations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323852      PMCID: PMC49793          DOI: 10.1073/pnas.89.16.7772

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.

Authors:  C Rooney; N Taylor; J Countryman; H Jenson; J Kolman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.

Authors:  J Countryman; H Jenson; R Seibl; H Wolf; G Miller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  Genomic organization of tRNA and aminoacyl-tRNA synthetase genes for two amino acids in Saccharomyces cerevisiae.

Authors:  C J Kolman; M Snyder; D Söll
Journal:  Genomics       Date:  1988-10       Impact factor: 5.736

5.  New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma.

Authors:  L Heston; M Rabson; N Brown; G Miller
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

6.  Epstein-Barr virus with heterogeneous DNA disrupts latency.

Authors:  G Miller; M Rabson; L Heston
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

7.  Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia.

Authors:  D F Patton; P Shirley; N Raab-Traub; L Resnick; J W Sixbey
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.

Authors:  M Rabson; L Gradoville; L Heston; G Miller
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

9.  Genome of a mononucleosis Epstein-Barr virus contains DNA fragments previously regarded to be unique to Burkitt's lymphoma isolates.

Authors:  D K Fischer; G Miller; L Gradoville; L Heston; M W Westrate; W Maris; J Wright; J Brandsma; W C Summers
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

10.  Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators.

Authors:  E Manet; H Gruffat; M C Trescol-Biemont; N Moreno; P Chambard; J F Giot; A Sergeant
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

View more
  7 in total

1.  Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.

Authors:  G Miller; L Heston; E Grogan; L Gradoville; M Rigsby; R Sun; D Shedd; V M Kushnaryov; S Grossberg; Y Chang
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

2.  Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.

Authors:  Kazufumi Ikuta; Mingyu Ding; Fangfang Zhang; John W Sixbey; Rona S Scott
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

3.  Points of recombination in Epstein-Barr virus (EBV) strain P3HR-1-derived heterogeneous DNA as indexes to EBV DNA recombinogenic events in vivo.

Authors:  Kazufumi Ikuta; Shamala K Srinivas; Tim Schacker; Jun-ichi Miyagi; Rona S Scott; John W Sixbey
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

4.  Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae.

Authors:  P S Moore; S J Gao; G Dominguez; E Cesarman; O Lungu; D M Knowles; R Garber; P E Pellett; D J McGeoch; Y Chang
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma.

Authors:  Dirk P Dittmer; Chelsey J Hilscher; Margaret L Gulley; Eric V Yang; Min Chen; Ronald Glaser
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

6.  Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity.

Authors:  David H Dreyfus
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

7.  In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha.

Authors:  P Randhawa; T Whiteside; A Zeevi; M Nalesnik; C Alvares; S M Gollin; J Demetris; J Locker
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Nov-Dec       Impact factor: 2.723

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.